Company registration number 14468386 (England and Wales)
PANDOX UK HOLDCO LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
PANDOX UK HOLDCO LIMITED
COMPANY INFORMATION
Directors
W M Adriaanse
A E Lindblom
S J Torner
B L Williams
Secretary
CSC CLS (UK) Limited
Company number
14468386
Registered office
5 Churchill Place, 10th Floor
London
United Kingdom
E14 5HU
Auditor
HaysMac LLP
10 Queen Street Place
London
EC4R 1AG
PANDOX UK HOLDCO LIMITED
CONTENTS
Page
Directors' report
1 - 2
Independent auditor's report
3 - 5
Profit and loss account
6
Balance sheet
7
Statement of changes in equity
8
Notes to the financial statements
9 - 17
PANDOX UK HOLDCO LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 1 -

The directors present their annual report and financial statements for the year ended 31 December 2024.

Principal activities

The principal activity of the company was that of an intermediate holding company.

Results and dividends

The results for the year are set out on page 6.

 

The company generated a pre-tax loss of £145,097 (2023:profit of £2,035,131). Net assets at 31 December 2024 stood at £40,211,098 (2023: £1,861,686).

 

No ordinary dividends were paid.

Directors

The directors who served during the period and subsequently to the date of this report are shown on the company information page.

Auditor

HaysMac LLP were appointed as auditor to the company and in accordance with section 485 of the Companies Act 2006, a resolution proposing that they be re-appointed will be put at a General Meeting.

Statement of directors' responsibilities

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

 

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

PANDOX UK HOLDCO LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -
Going concern

The company is wholly reliant, for the foreseeable future, on the continued financial support from its ultimate parent company, Pandox AB, in order to meet its obligations as and when they fall due.

 

Management have reforecasted the expected financial performance and cash flows for the period up to 30 September 2026 and performed additional sensitivity analysis in order to understand the level of support that may be required. This has been discussed with Pandox AB and a letter of support has been provided to the Board of Directors.

 

Whilst the letter of support is not legally binding the Board of Directors believe that the company will be provided financial support from Pandox AB in order for the company to meet its obligations as and when they fall due until at least 30 September 2026. The Directors have also considered the financial position of Pandox AB and concluded that they have sufficient financial resources with which to provide the support detailed in the letter.

 

Therefore on the basis of the above, the Directors have approved the financial statements utilising the going concern basis of preparation.

Small companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

On behalf of the board
B L Williams
Director
24 September 2025
PANDOX UK HOLDCO LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF PANDOX UK HOLDCO LIMITED
- 3 -
Opinion

We have audited the financial statements of Pandox UK Holdco Limited (the 'company') for the year ended 31 December 2024 which comprise the profit and loss account, the balance sheet, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the directors' report. We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

 

PANDOX UK HOLDCO LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF PANDOX UK HOLDCO LIMITED
- 4 -
Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Explanation as to what extent the audit was considered capable of detecting irregularities , including fraud

Based on our understanding of the company and industry, we considered those laws and regulations that have a direct impact on the preparation of the financial statements.

 

We evaluated management’s incentives and opportunities for fraudulent manipulation of the financial statements (including the risk of override of controls) and determined that the principal risk was management bias in accounting estimates. Audit procedures performed by the engagement team included:

 

- Discussions with management including consideration of known or suspected instances of non-compliance with laws and regulation and fraud;

- Evaluating management’s controls designed to prevent and detect irregularities;

- Identifying and reviewing journals, in particular journal entries which shared key risk characteristics; and

- Challenging assumptions and judgements made by management in their critical accounting estimates. This included but was not limited to intercompany debt recoverability.

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance.

The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

PANDOX UK HOLDCO LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF PANDOX UK HOLDCO LIMITED
- 5 -
........................
Mr Andrew Ball
Senior Statutory Auditor
For and on behalf of HaysMac LLP
25 September 2025
Chartered Accountants
Statutory Auditor
10 Queen Street Place
London
EC4R 1AG
PANDOX UK HOLDCO LIMITED
PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 6 -
Period
14 months
ended
ended
31 December
31 December
2024
2023
Notes
£
£
Administrative expenses
(332,207)
(190,625)
Other operating income
111,347
90,456
Operating loss
(220,860)
(100,169)
Interest receivable and similar income
5
5,386,751
3,347,377
Interest payable and similar expenses
6
(5,310,988)
(1,212,077)
(Loss)/profit before taxation
(145,097)
2,035,131
Tax on (loss)/profit
7
(330,701)
(173,446)
(Loss)/profit for the financial year
(475,798)
1,861,685

The profit and loss account has been prepared on the basis that all operations are continuing operations.

There were no recognised gains and losses for the period ended 31 December 2024 other than those included in the profit and loss account.

The notes on pages 9 to 17 form part of these financial statements.

PANDOX UK HOLDCO LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
31 December 2024
- 7 -
2024
2023
Notes
£
£
£
£
Fixed assets
Investments
8
43,872,705
30,924,132
Current assets
Debtors
10
84,939,998
63,498,984
Cash at bank and in hand
1,654,627
124,851
86,594,625
63,623,835
Creditors: amounts falling due within one year
11
(1,779,835)
(53,474,429)
Net current assets
84,814,790
10,149,406
Total assets less current liabilities
128,687,495
41,073,538
Creditors: amounts falling due after more than one year
12
(88,476,397)
(39,211,852)
Net assets
40,211,098
1,861,686
Capital and reserves
Called up share capital
13
3
1
Share premium account
14
38,825,208
-
0
Profit and loss reserves
1,385,887
1,861,685
Total equity
40,211,098
1,861,686

The notes on pages 9 to 17 form part of these financial statements.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 24 September 2025 and are signed on its behalf by:
B L Williams
Director

The notes on pages 9 to 17 form part of these financial statements.

PANDOX UK HOLDCO LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024
- 8 -
Share capital
Share premium account
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 7 November 2022
1
-
0
-
0
1
Period ended 31 December 2023:
Profit and total comprehensive income for the period
-
-
1,861,685
1,861,685
Balance at 31 December 2023
1
-
0
1,861,685
1,861,686
Year ended 31 December 2024:
Loss and total comprehensive income for the year
-
-
(475,798)
(475,798)
Issue of share capital
13
2
38,825,208
-
38,825,210
Balance at 31 December 2024
3
38,825,208
1,385,887
40,211,098

The notes on pages 9 to 17 form part of these financial statements.

PANDOX UK HOLDCO LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 9 -
1
Accounting policies
Company information

Pandox UK Holdco Limited is a private company limited by shares incorporated in England and Wales. The registered office is 5 Churchill Place, 10th Floor, London, United Kingdom, E14 5HU.

1.1
Reporting period

The Company's financial year starts 1 January and ends 31 December except for the prior period. The prior financial statements were prepared for a 14 months which started from the date of incorporation i.e. 7 November 2022 until 31 December 2023.

1.2
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional and presentational currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.3
Going concern

The company is wholly reliant, for the foreseeable future, on the continued financial support from itstrue ultimate parent company, Pandox AB, in order to meet its obligations as and when they fall due for the foreseeable future.

 

Management have reforecasted the expected financial performance and cash flows for the period up to 30 September 2026 and performed additional sensitivity analysis in order to understand the level of support that may be required. This has been discussed with Pandox AB and a letter of support has been provided to the Board of Directors.

 

Whilst the letter of support is not legally binding the Board of Directors believe that the company will be provided financial support from Pandox AB in order for the company to meet its obligations as and when they fall due until at least 30 September 2026. The Directors have also considered the financial position of Pandox AB and concluded that they have sufficient financial resources with which to provide the support detailed in the letter.

 

Therefore on the basis of the above, the Directors have approved the financial statements utilising the going concern basis of preparation.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.5
Financial instruments

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

PANDOX UK HOLDCO LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 10 -
Fair value measurement of financial instruments

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Profit and loss account.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classifies as current liabilities is payment is due within one year or less. If not, they are presented as non-current liabilities.

1.6
Derivatives

Derivatives are initially recognised at fair value at the date a derivative contract is entered into and are subsequently remeasured to fair value at each reporting end date. The resulting gain or loss is recognised in profit or loss immediately.

 

A derivative with a positive fair value is recognised as a financial asset, whereas a derivative with a negative fair value is recognised as a financial liability.

 

The company does not currently apply hedge accounting for interest rate derivatives. The company uses derivative financial instruments to reduce exposure to interest rate movements. The company does not hold or issue derivative financial instruments for speculative purposes.

 

1.7
Taxation
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.8
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

PANDOX UK HOLDCO LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 11 -
1.9

Valuation of Investments

Investments in subsidiaries are measured at cost less accumulated impairment.

 

If an impairment loss is identified, this is recognised immediately in the profit and loss account and the value of the investment is reduced accordingly.

1.10

Interest Income and Interest Expense

Interest income and interest expense, including those arising from intercompany loans, are recognised on an accruals basis, unless the impact of discounting is immaterial.

 

Intercompany interest receivable and payable is recognised in the statement of comprehensive income within finance income or finance costs, respectively. Any unpaid amounts are recorded in the statement of financial position as part of trade and other receivables or trade and other payables.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Critical judgements

The following judgements (apart from those involving estimates) have had the most significant effect on amounts recognised in the financial statements.

Valuation of Investments

Investments in subsidiaries are measured at cost less accumulated impairment.

 

If a impairment loss is identified, this is recognised immediately in the profit and loss account and the value of the investments is reduces accordingly.

Recoverability of debtors

Intercompany receivables are recognised to the extent that they are judged recoverable. Director reviews are performed to estimate the level of reserves required for irrecoverable debt, considering customer credit worthiness, current economic trends and changes in customer payment terms. Provisions are made specifically against invoices where recoverability is uncertain.

3
Auditor's remuneration
2024
2023
Fees payable to the company's auditor and associates:
£
£
For audit services
Audit of the financial statements of the company
12,700
10,000
4
Employees

The company has no employees other than the directors, who did not receive any remuneration.

PANDOX UK HOLDCO LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 12 -
5
Interest receivable and similar income
2024
2023
£
£
Interest receivable and similar income includes the following:
Interest on bank deposits
13,063
9,246
SWAP interest
293,114
-
0
Interest receivable from group companies
5,080,574
3,338,131
Total
5,386,751
3,347,377
6
Interest payable and similar expenses
2024
2023
£
£
Interest payable and similar expenses includes the following:
Interest on bank loans
2,761,450
-
Interest payable to group undertakings
2,235,808
1,212,077
Other interest on financial liabilities
206,537
-
Finance costs on loans
107,193
-
Total
5,310,988
1,212,077
7
Taxation
2024
2023
£
£
Current tax
UK corporation tax on profits for the current period
-
0
173,446
Adjustments in respect of prior periods
330,701
-
0
Total current tax
330,701
173,446
PANDOX UK HOLDCO LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
7
Taxation
(Continued)
- 13 -

The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:

2024
2023
£
£
(Loss)/profit before taxation
(145,097)
2,035,131
Expected tax (credit)/charge based on the standard rate of corporation tax in the UK of 25.00% (2023: 23.50%)
(36,274)
478,256
Tax effect of expenses that are not deductible in determining taxable profit
61,760
32,186
Tax effect of income not taxable in determining taxable profit
(163,322)
-
0
Adjustments in respect of prior years
330,701
-
0
Group relief
137,836
(336,996)
Taxation charge for the year
330,701
173,446
Opening and closing deferred tax balances are calculated at a rate of 25%.
PANDOX UK HOLDCO LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 14 -
8
Fixed asset investments
2024
2023
£
£
Shares in group undertakings and participating interests
43,872,705
30,924,132
Movements in fixed asset investments
Shares in subsidiaries
2024
Cost or valuation
£
At 1 January 2024
30,924,132
Additions
12,948,573
At 31 December 2024
43,872,705
Carrying amount
At 31 December 2024
43,872,705
At 31 December 2023
30,924,132
On the 16 February 2023 the company acquired the entire share capital of Pandox Leeds City Centre Limited.
On the 20 July 2023 the company acquired the entire share capital of Pandox Belfast Limited.
On the 6 March 2024 the company acquired the entire share capital of Pandox Bath Limited.
9
Subsidiaries

Details of the company's subsidiaries at 31 December 2024 are as follows:

Name of undertaking
Address
Class of
% Held
shares held
Direct
Pandox Leeds City Centre
1
Ordinary
100.00
Pandox Belfast Limited
2
Ordinary
100.00
Pandox Bath Limited
3
Ordinary
100.00

Registered office addresses (all UK unless otherwise indicated):

1
5 Churchill Place, 10th Floor, London, United Kingdom, E14 5HU
2
Hilton Belfast, 4 Lanyon Place, Belfast, Northern Ireland, BT1 3LP
3
Clyde Offices, 2nd Floor, 48 West George Street, Glasgow, Scotland, G2 1BP
PANDOX UK HOLDCO LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 15 -
10
Debtors
2024
2023
Amounts falling due within one year:
£
£
Amounts owed by group undertakings
10,981,579
50,838,033
Other debtors
347,405
334,951
11,328,984
51,172,984
Amounts owed by group undertakings falling due within one year are interest free and repayable on demand.
2024
2023
Amounts falling due after more than one year:
£
£
Amounts owed by group undertakings
73,611,014
12,326,000
Total debtors
84,939,998
63,498,984

Amounts owed by group undertakings falling due after more than one year consist of three loans receivable from a fellow group undertaking.

 

The first loan is for the amount of £7,706,678 which bears interest at the rate of 700 bps per annum, capitalized quarterly in arrears and is repayable in July 2028.

 

The second loan is for the amount of £41,301,336 which bears interest at the rate of 700 bps per annum, capitalized quarterly in arrears and is repayable in February 2028.

 

The third loan is for the amount of £24,603,000 which bears interest at the rate of 700 bps per annum, capitalized quarterly in arrears and is repayable in July 2028.

11
Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
73,342
-
0
Amounts owed to group undertakings
-
0
53,281,983
Corporation tax
303,647
173,446
Derivative financial instruments
206,537
-
0
Accruals
1,196,309
19,000
1,779,835
53,474,429

The Company entered into two GBP interest rate swaps to receive interest at Sonia and pay interest at a fixed 4,114% and 4,116%. The swaps are based on a principal amount of GBP 28.800,000 each, the principal amount of the loan facility, and matures in 2029 on the same date as the loan.

PANDOX UK HOLDCO LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 16 -
12
Creditors: amounts falling due after more than one year
2024
2023
£
£
Bank loans and overdrafts
63,247,324
-
0
Amounts owed to group undertakings
25,229,073
39,211,852
88,476,397
39,211,852

Bank loans and overdrafts relates to a promissory loan note. This consists of a GBP facility loan of £64,000,000 bearing interest of Sonia + 2.50%. The repayment date is 31 May 2029 or where the loan to value of the properties held in the three subsidiaries, is higher than 50%.

 

Amounts owed to group undertakings accrue interest at a fixed rate of 7.00% per annum, capitalized quarterly in arrears. The repayment date is 19 July 2028.

 

 

13
Called up share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
1 of £1 each
3
1
3
1
14
Share premium account
2024
2023
£
£
At the beginning of the year
-
0
-
0
Issue of new shares
38,825,208
-
0
At the end of the year
38,825,208
-
0

On the 6 March 2024 the Company became the sole shareholder of Pandox Bath Limited as a result of an internal restructure. The Investment value of Pandox Bath Limited for the total value of £12,948,573 was transferred from the immediate parent company SECH Holdings AB. in consideration of 1 ordinary share issued at a premium of £12,948,573.

 

In addition an intercompany loan receivable from Pandox Bath Limited was assigned to the Company from SECH Holdings AB for the total amount of £25,876,635 in consideration of 1 ordinary share issued at a premium of £25,876,635

PANDOX UK HOLDCO LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 17 -
15
Controlling party

The immediate parent undertaking is SECH Holding AB, a company registered in Sweden. The largest and smallest group to consolidate the results of this company are the group headed by Pandox AB. The ultimate parent undertaking is Pandox AB, a company registered in Sweden. Financial statements for Pandox AB are available from the following website: https://www.pandox.se/investor-relations/financial-reports-andpresentations/

 

There is no individual ultimate controlling party

2024-12-312024-01-01falseCCH SoftwareCCH Accounts Production 2024.100W M AdriaanseA E LindblomS J TornerB L WilliamsCSC CLS (UK) Limitedfalsefalse0144683862024-01-012024-12-3114468386bus:Director12024-01-012024-12-3114468386bus:Director22024-01-012024-12-3114468386bus:Director32024-01-012024-12-3114468386bus:Director42024-01-012024-12-3114468386bus:CompanySecretary12024-01-012024-12-3114468386bus:RegisteredOffice2024-01-012024-12-31144683862024-12-31144683862022-11-072023-12-3114468386core:RetainedEarningsAccumulatedLosses2022-11-072023-12-3114468386core:RetainedEarningsAccumulatedLosses2024-01-012024-12-31144683862023-12-3114468386core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3114468386core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3114468386core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3114468386core:Non-currentFinancialInstrumentscore:AfterOneYear2023-12-3114468386core:CurrentFinancialInstruments2024-12-3114468386core:CurrentFinancialInstruments2023-12-3114468386core:Non-currentFinancialInstruments2024-12-3114468386core:Non-currentFinancialInstruments2023-12-3114468386core:ShareCapital2024-12-3114468386core:ShareCapital2023-12-3114468386core:SharePremium2024-12-3114468386core:SharePremium2023-12-3114468386core:RetainedEarningsAccumulatedLosses2024-12-3114468386core:RetainedEarningsAccumulatedLosses2023-12-3114468386core:ShareCapital2022-11-0614468386core:SharePremium2022-11-0614468386core:RetainedEarningsAccumulatedLosses2022-11-0614468386core:SharePremium2023-12-3114468386core:ShareCapital2024-01-012024-12-3114468386core:SharePremium2024-01-012024-12-3114468386core:SharePremium2022-11-072023-12-311446838612022-11-072023-12-3114468386core:UKTax2024-01-012024-12-3114468386core:UKTax2022-11-072023-12-3114468386bus:PrivateLimitedCompanyLtd2024-01-012024-12-3114468386bus:FRS1022024-01-012024-12-3114468386bus:Audited2024-01-012024-12-3114468386bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP